BUKWANG PHARMACEUTICAL IND CO.,LTD
An R&D-focused company developing drugs for CNS disorders and oncology.
003000 | KO
Overview
Corporate Details
- ISIN(s):
- KR7003000007
- LEI:
- Country:
- South Korea
- Address:
- 서울특별시 동작구 대방동1길 47, 서울특별시
- Website:
- https://www.bukwang.co.kr/en/
- Sector:
- Manufacturing
Description
Bukwang Pharmaceutical is a research and development-focused company that develops, produces, and sells a range of pharmaceutical and oral hygienic products. The company emphasizes an open innovation strategy, leveraging joint ventures, research collaborations, and strategic investments to build a robust drug pipeline. Its key development areas include treatments for central nervous system disorders like schizophrenia, bipolar depression, and dyskinesia in Parkinson's disease. The pipeline also features oncology candidates, such as a treatment for metastatic prostate cancer. Bukwang Pharmaceutical manufactures various dosage forms, including oral solids and injections, alongside over-the-counter medications.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-03-04 00:00 |
주주총회집중일개최사유신고
|
Korean | 4.4 KB | ||
| 2022-03-03 00:00 |
최대주주등소유주식변동신고서(최대주주변경시)
|
Korean | 117.8 KB | ||
| 2022-03-03 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 122.5 KB | ||
| 2022-03-03 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.8 KB | ||
| 2022-03-03 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 129.9 KB | ||
| 2022-03-03 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 23.0 KB | ||
| 2022-03-03 00:00 |
최대주주변경
|
Korean | 18.2 KB | ||
| 2022-03-02 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 138.6 KB | ||
| 2022-03-02 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.8 KB | ||
| 2022-03-02 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 135.2 KB | ||
| 2022-03-02 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 131.6 KB | ||
| 2022-03-02 00:00 |
[기재정정]단일판매ㆍ공급계약체결
|
Korean | 11.3 KB | ||
| 2022-02-22 00:00 |
투자판단관련주요경영사항
|
Korean | 8.4 KB | ||
| 2022-02-14 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변경
|
Korean | 14.2 KB | ||
| 2022-01-05 00:00 |
주식등의대량보유상황보고서(약식)
|
Korean | 54.2 KB |
Automate Your Workflow. Get a real-time feed of all BUKWANG PHARMACEUTICAL IND CO.,LTD filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for BUKWANG PHARMACEUTICAL IND CO.,LTD
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for BUKWANG PHARMACEUTICAL IND CO.,LTD via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
